ENTRY       K17719                      KO
NAME        CYP2C9
DEFINITION  cytochrome P450, family 2, subfamily C, polypeptide 9 [EC:1.14.13.48 1.14.13.49 1.14.13.80 1.14.13.-]
PATHWAY     ko00590  Arachidonic acid metabolism
            ko00591  Linoleic acid metabolism
            ko00830  Retinol metabolism
            ko00980  Metabolism of xenobiotics by cytochrome P450
            ko00982  Drug metabolism - cytochrome P450
            ko04726  Serotonergic synapse
            ko05204  Chemical carcinogenesis
DISEASE     H01205  Coumarin resistance
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Metabolism
              Lipid metabolism
               00590 Arachidonic acid metabolism
                K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
               00591 Linoleic acid metabolism
                K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
              Metabolism of cofactors and vitamins
               00830 Retinol metabolism
                K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
              Xenobiotics biodegradation and metabolism
               00980 Metabolism of xenobiotics by cytochrome P450
                K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
               00982 Drug metabolism - cytochrome P450
                K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
             Organismal Systems
              Nervous system
               04726 Serotonergic synapse
                K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
             Human Diseases
              Cancers
               05204 Chemical carcinogenesis
                K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
            Enzymes [BR:ko01000]
             1. Oxidoreductases
              1.14  Acting on paired donors with incorporation of molecular oxygen
               1.14.13  With NADH or NADPH as one donor, and incorporation of one atom of oxygen into the other donor
                1.14.13.48  (S)-limonene 6-monooxygenase
                 K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
                1.14.13.49  (S)-limonene 7-monooxygenase
                 K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
                1.14.13.80  (R)-limonene 6-monooxygenase
                 K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
                1.14.13.-  
                 K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
            Cytochrome P450 [BR:ko00199]
             Cytochrome P450, animal type
              CYP2 family
               K17719  CYP2C9; cytochrome P450, family 2, subfamily C, polypeptide 9
DBLINKS     RN: R07048 R07050 R07051 R07055 R07056 R07079 R07080 R07081 R07085 R07087 R08267 R08275 R08285 R08324 R08325 R08326 R08390 R08392
            GO: 0018675 0018676 0052741
GENES       HSA: 1559(CYP2C9)
            PTR: 100616515
            PPS: 100996034
            PON: 100450749
            MCF: 102147103(CYP2C75)
            MYD: 102759998
REFERENCE   PMID:19545642
  AUTHORS   Iliff JJ, Jia J, Nelson J, Goyagi T, Klaus J, Alkayed NJ
  TITLE     Epoxyeicosanoid signaling in CNS function and disease.
  JOURNAL   Prostaglandins Other Lipid Mediat 91:68-84 (2010)
///
